1. Essential thrombocythemia;Tefferi;N. Engl. J. Med.,2019
2. A concise update on risk factors, therapy, and outcome of leukemic transformation of myeloproliferative neoplasms;Mascarenhas;Clin. Lymphoma Myeloma Leuk.,2016
3. Myeloproliferative neoplasms;Spivak;N. Engl. J. Med.,2017
4. JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients;Coucelo;Int. J. Hematol.,2014
5. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status;Arellano-Rodrigo;Haematologica,2006